Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) traded down 4.2% during trading on Monday . The stock traded as low as $384.50 and last traded at $396.8360. 862 shares changed hands during trading, a decline of 95% from the average session volume of 17,966 shares. The stock had previously closed at $414.3680.
Roche Trading Up 0.8%
The company has a fifty day moving average price of $404.96 and a 200 day moving average price of $418.71.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Further Reading
- Five stocks we like better than Roche
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
